SCHEMBL20735933

SCHEMBL20735933

CCCc1nc2ccccc2n1-c1ccc(-c2ccc3cc4c(cc3c2)C2(c3ccccc3-c3ccccc32)c2c-4ccc3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.39
CYP1A2 P05177 2/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
USP2 O75604 1/20 0.36
PPARG P37231 6/20 0.35
BLM P54132 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
HKDC1 Q2TB90 1/20 0.33
MAPT P10636 1/20 0.33
KCNH2 Q12809 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
FLT3 P36888 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737753 0.96 PDE10A (0.39) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL20737305 0.94 USP2 (0.39) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL20735938 0.93 PDE10A (0.37) PDE10ACYP1A2MEN1KMT2ASMN1; SMN2
SCHEMBL20737170 0.91 PDE10A (0.39) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL27250598 0.91 CYP1A2 (0.43) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL20735955 0.90 PDE10A (0.39) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL20737748 0.89 PDE10A (0.37) PDE10ACYP1A2MEN1KMT2AMAPT
SCHEMBL27250405 0.88 CYP1A2 (0.37) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL27250527 0.88 PDE10A (0.39) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL27250554 0.88 PDE10A (0.36) PDE10ACYP1A2MEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885MEN1 635/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885MEN1 635/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885MEN1 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.